The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Buprenorphine Hydrochloride Market Research Report 2024
Synopsis
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
The global Buprenorphine Hydrochloride market was valued at US$ 138.5 million in 2023 and is anticipated to reach US$ 158.3 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
This report aims to provide a comprehensive presentation of the global market for Buprenorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buprenorphine Hydrochloride.
Report Scope
The Buprenorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Buprenorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buprenorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Segment by Type
Tablets
Injection
Segment by Application
Analgesic
Opioid Antagonist
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Buprenorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Buprenorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
The global Buprenorphine Hydrochloride market was valued at US$ 138.5 million in 2023 and is anticipated to reach US$ 158.3 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
This report aims to provide a comprehensive presentation of the global market for Buprenorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buprenorphine Hydrochloride.
Report Scope
The Buprenorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Buprenorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buprenorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Segment by Type
Tablets
Injection
Segment by Application
Analgesic
Opioid Antagonist
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Buprenorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Buprenorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Buprenorphine Hydrochloride Market Overview
1.1 Product Overview and Scope of Buprenorphine Hydrochloride
1.2 Buprenorphine Hydrochloride Segment by Type
1.2.1 Global Buprenorphine Hydrochloride Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Injection
1.3 Buprenorphine Hydrochloride Segment by Application
1.3.1 Global Buprenorphine Hydrochloride Market Value by Application: (2024-2030)
1.3.2 Analgesic
1.3.3 Opioid Antagonist
1.4 Global Buprenorphine Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Buprenorphine Hydrochloride Revenue 2019-2030
1.4.2 Global Buprenorphine Hydrochloride Sales 2019-2030
1.4.3 Global Buprenorphine Hydrochloride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Buprenorphine Hydrochloride Market Competition by Manufacturers
2.1 Global Buprenorphine Hydrochloride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Buprenorphine Hydrochloride Average Price by Manufacturers (2019-2024)
2.4 Global Buprenorphine Hydrochloride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Buprenorphine Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buprenorphine Hydrochloride, Product Type & Application
2.7 Buprenorphine Hydrochloride Market Competitive Situation and Trends
2.7.1 Buprenorphine Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Buprenorphine Hydrochloride Players Market Share by Revenue
2.7.3 Global Buprenorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Buprenorphine Hydrochloride Retrospective Market Scenario by Region
3.1 Global Buprenorphine Hydrochloride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Buprenorphine Hydrochloride Global Buprenorphine Hydrochloride Sales by Region: 2019-2030
3.2.1 Global Buprenorphine Hydrochloride Sales by Region: 2019-2024
3.2.2 Global Buprenorphine Hydrochloride Sales by Region: 2025-2030
3.3 Global Buprenorphine Hydrochloride Global Buprenorphine Hydrochloride Revenue by Region: 2019-2030
3.3.1 Global Buprenorphine Hydrochloride Revenue by Region: 2019-2024
3.3.2 Global Buprenorphine Hydrochloride Revenue by Region: 2025-2030
3.4 North America Buprenorphine Hydrochloride Market Facts & Figures by Country
3.4.1 North America Buprenorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Buprenorphine Hydrochloride Sales by Country (2019-2030)
3.4.3 North America Buprenorphine Hydrochloride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Buprenorphine Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Buprenorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Buprenorphine Hydrochloride Sales by Country (2019-2030)
3.5.3 Europe Buprenorphine Hydrochloride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buprenorphine Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Buprenorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Buprenorphine Hydrochloride Sales by Country (2019-2030)
3.6.3 Asia Pacific Buprenorphine Hydrochloride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Buprenorphine Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Buprenorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Buprenorphine Hydrochloride Sales by Country (2019-2030)
3.7.3 Latin America Buprenorphine Hydrochloride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Buprenorphine Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Buprenorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Buprenorphine Hydrochloride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Buprenorphine Hydrochloride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Buprenorphine Hydrochloride Sales by Type (2019-2030)
4.1.1 Global Buprenorphine Hydrochloride Sales by Type (2019-2024)
4.1.2 Global Buprenorphine Hydrochloride Sales by Type (2025-2030)
4.1.3 Global Buprenorphine Hydrochloride Sales Market Share by Type (2019-2030)
4.2 Global Buprenorphine Hydrochloride Revenue by Type (2019-2030)
4.2.1 Global Buprenorphine Hydrochloride Revenue by Type (2019-2024)
4.2.2 Global Buprenorphine Hydrochloride Revenue by Type (2025-2030)
4.2.3 Global Buprenorphine Hydrochloride Revenue Market Share by Type (2019-2030)
4.3 Global Buprenorphine Hydrochloride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Buprenorphine Hydrochloride Sales by Application (2019-2030)
5.1.1 Global Buprenorphine Hydrochloride Sales by Application (2019-2024)
5.1.2 Global Buprenorphine Hydrochloride Sales by Application (2025-2030)
5.1.3 Global Buprenorphine Hydrochloride Sales Market Share by Application (2019-2030)
5.2 Global Buprenorphine Hydrochloride Revenue by Application (2019-2030)
5.2.1 Global Buprenorphine Hydrochloride Revenue by Application (2019-2024)
5.2.2 Global Buprenorphine Hydrochloride Revenue by Application (2025-2030)
5.2.3 Global Buprenorphine Hydrochloride Revenue Market Share by Application (2019-2030)
5.3 Global Buprenorphine Hydrochloride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Siegfried
6.1.1 Siegfried Corporation Information
6.1.2 Siegfried Description and Business Overview
6.1.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Siegfried Buprenorphine Hydrochloride Product Portfolio
6.1.5 Siegfried Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Buprenorphine Hydrochloride Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Johnson Matthey
6.3.1 Johnson Matthey Corporation Information
6.3.2 Johnson Matthey Description and Business Overview
6.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson Matthey Buprenorphine Hydrochloride Product Portfolio
6.3.5 Johnson Matthey Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Corporation Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mallinckrodt Buprenorphine Hydrochloride Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Noramco
6.5.1 Noramco Corporation Information
6.5.2 Noramco Description and Business Overview
6.5.3 Noramco Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Noramco Buprenorphine Hydrochloride Product Portfolio
6.5.5 Noramco Recent Developments/Updates
6.6 Unichemlabs
6.6.1 Unichemlabs Corporation Information
6.6.2 Unichemlabs Description and Business Overview
6.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Unichemlabs Buprenorphine Hydrochloride Product Portfolio
6.6.5 Unichemlabs Recent Developments/Updates
6.7 Arevipharma
6.6.1 Arevipharma Corporation Information
6.6.2 Arevipharma Description and Business Overview
6.6.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Arevipharma Buprenorphine Hydrochloride Product Portfolio
6.7.5 Arevipharma Recent Developments/Updates
6.8 Resonance-labs
6.8.1 Resonance-labs Corporation Information
6.8.2 Resonance-labs Description and Business Overview
6.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Resonance-labs Buprenorphine Hydrochloride Product Portfolio
6.8.5 Resonance-labs Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Corporation Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharma Buprenorphine Hydrochloride Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Rusan Pharma
6.10.1 Rusan Pharma Corporation Information
6.10.2 Rusan Pharma Description and Business Overview
6.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Rusan Pharma Buprenorphine Hydrochloride Product Portfolio
6.10.5 Rusan Pharma Recent Developments/Updates
6.11 Micro Orgo Chem
6.11.1 Micro Orgo Chem Corporation Information
6.11.2 Micro Orgo Chem Buprenorphine Hydrochloride Description and Business Overview
6.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Product Portfolio
6.11.5 Micro Orgo Chem Recent Developments/Updates
6.12 Faranshimi
6.12.1 Faranshimi Corporation Information
6.12.2 Faranshimi Buprenorphine Hydrochloride Description and Business Overview
6.12.3 Faranshimi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Faranshimi Buprenorphine Hydrochloride Product Portfolio
6.12.5 Faranshimi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buprenorphine Hydrochloride Industry Chain Analysis
7.2 Buprenorphine Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buprenorphine Hydrochloride Production Mode & Process
7.4 Buprenorphine Hydrochloride Sales and Marketing
7.4.1 Buprenorphine Hydrochloride Sales Channels
7.4.2 Buprenorphine Hydrochloride Distributors
7.5 Buprenorphine Hydrochloride Customers
8 Buprenorphine Hydrochloride Market Dynamics
8.1 Buprenorphine Hydrochloride Industry Trends
8.2 Buprenorphine Hydrochloride Market Drivers
8.3 Buprenorphine Hydrochloride Market Challenges
8.4 Buprenorphine Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
